Published in Clin Epidemiol on January 09, 2015
Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop (2016) 0.84
Low-Level Cadmium Exposure Is Associated With Decreased Bone Mineral Density and Increased Risk of Incident Fractures in Elderly Men: The MrOS Sweden Study. J Bone Miner Res (2015) 0.82
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int (2015) 0.79
Effect of Stem Cell Therapy on Bone Mineral Density: A Meta-Analysis of Preclinical Studies in Animal Models of Osteoporosis. PLoS One (2016) 0.77
Epigenetics of Osteoporosis: Critical Analysis of Epigenetic Epidemiology Studies. Curr Genomics (2015) 0.76
Genetics of aging bone. Mamm Genome (2016) 0.76
Prevalence and Risk Factors of Osteoporosis in Women Referring to the Bone Densitometry Academic Center in Urmia, Iran. Glob J Health Sci (2015) 0.75
Age-Related Loss in Bone Mineral Density of Rats Fed Lifelong on a Fish Oil-Based Diet Is Avoided by Coenzyme Q10 Addition. Nutrients (2017) 0.75
Relationship between Blood Mercury Concentration and Bone Mineral Density in Korean Men in the 2008-2010 Korean National Health and Nutrition Examination Survey. Korean J Fam Med (2016) 0.75
Correlation between bone mineral density and serum trace element contents of elderly males in Beijing urban area. Int J Clin Exp Med (2015) 0.75
Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative. Gerontologist (2016) 0.75
The Adequacy of Diagnosis and Treatment for Osteoporosis in Patients with Proximal Humeral Fractures. Clin Orthop Surg (2016) 0.75
Association between essential hypertension and bone mineral density: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Loss of Bone Mineral Density Associated with Age in Male Rats Fed on Sunflower Oil Is Avoided by Virgin Olive Oil Intake or Coenzyme Q Supplementation. Int J Mol Sci (2017) 0.75
The effect of atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (HMG-CoA), on the prevention of osteoporosis in ovariectomized rabbits. J Bone Miner Metab (2016) 0.75
Risk of Sarcopenia and Osteoporosis in Male Tuberculosis Survivors: Korea National Health and Nutrition Examination Survey. Sci Rep (2017) 0.75
A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis. Osteoporos Int (2017) 0.75
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med (2007) 7.38
Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med (2009) 6.67
Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev (2002) 6.38
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Incidence and mortality of hip fractures in the United States. JAMA (2009) 6.05
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med (2011) 5.46
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) (2010) 4.65
A reference standard for the description of osteoporosis. Bone (2007) 3.67
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
Trends in hip fracture rates in Canada. JAMA (2009) 2.95
Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int (2009) 2.63
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53
Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res (2003) 2.48
Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 1.96
Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93
Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res (2010) 1.90
Osteoporosis in men. Endocr Rev (2008) 1.80
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2010) 1.76
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int (2008) 1.68
The societal burden of osteoporosis. Curr Rheumatol Rep (2010) 1.65
Bone parameters across different types of hip osteoarthritis and their relationship to osteoporotic fracture risk. Arthritis Rheum (2013) 1.65
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int (2004) 1.57
Retracted Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med (2005) 1.53
Peak bone mass. Osteoporos Int (1994) 1.52
Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician (2002) 1.46
Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab (2012) 1.37
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Medical costs of osteoporosis in the elderly Medicare population. Osteoporos Int (2010) 1.29
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics (2010) 1.27
Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res (2001) 1.27
Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int (2009) 1.25
Osteoporosis in inflammatory joint diseases. Osteoporos Int (2010) 1.21
Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2012) 1.19
Osteoporosis in men. Best Pract Res Clin Endocrinol Metab (2011) 1.19
Alcohol consumption and hip fractures: the Framingham Study. Am J Epidemiol (1988) 1.14
The structural and biomechanical basis of the gain and loss of bone strength in women and men. Endocrinol Metab Clin North Am (2003) 1.12
Growth in bone mass and size--are racial and gender differences in bone mineral density more apparent than real? J Clin Endocrinol Metab (1998) 1.10
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. J Clin Endocrinol Metab (2012) 1.09
Ethnic difference of clinical vertebral fracture risk. Osteoporos Int (2011) 1.08
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int (2008) 1.04
Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway. Age Ageing (2011) 1.04
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler (2011) 1.03
Osteoporosis in multiple sclerosis. Mult Scler (2010) 1.02
Osteoporosis in men. Endocrinol Metab Clin North Am (2007) 1.02
Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res (2011) 1.00
The epidemic of hip fractures: are we on the right track? PLoS One (2011) 0.99
Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int (2012) 0.99
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Hip fracture in men-survival and subsequent fractures: a cohort study with 22-year follow-up. J Am Geriatr Soc (2011) 0.97
Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study. J Bone Miner Res (2003) 0.96
Economic burden of osteoporosis-related fractures in Medicaid. Value Health (2007) 0.95
Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int (2008) 0.94
Hip fractures in the United States: 2008 nationwide emergency department sample. Arthritis Care Res (Hoboken) (2012) 0.93
Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab (2013) 0.92
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden. Eur J Cancer (2012) 0.92
Worldwide uptake of FRAX. Arch Osteoporos (2014) 0.91
The mutual dependence between bone and gonads. J Endocrinol (2012) 0.89
The pathogenesis, treatment and prevention of osteoporosis in men. Drugs (2013) 0.88
Implications in the use of T-scores for the diagnosis of osteoporosis in men. J Clin Densitom (2002) 0.88
Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care (2011) 0.88
Emergency department visits due to vertebral fractures in the Netherlands, 1986-2008: steep increase in the oldest old, strong association with falls. Injury (2011) 0.87
Male osteoporosis: epidemiology and the pathogenesis of aging bones. Curr Osteoporos Rep (2011) 0.87
Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int (2010) 0.87
The intensity of physical activity influences bone mineral accrual in childhood: the childhood health, activity and motor performance school (the CHAMPS) study, Denmark. BMC Pediatr (2013) 0.86
Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. Am J Cardiol (2012) 0.86
Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions. J Clin Densitom (2013) 0.86
Osteoporosis and vertebral fractures in men aged 60-74 years. Age Ageing (2012) 0.85
Incidence of subsequent hip fractures is significantly increased within the first month after distal radius fracture in patients older than 60 years. J Trauma Acute Care Surg (2013) 0.84
2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases. J Clin Densitom (2013) 0.83
Male osteoporosis: A review. World J Orthop (2012) 0.83
Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007). Arthritis Care Res (Hoboken) (2012) 0.83
The burden of illness of osteoporosis in Canadian men. J Bone Miner Res (2012) 0.82
Osteoporosis in men: recent progress. Endocrine (2013) 0.82
Androgens and bone. Minerva Endocrinol (2012) 0.82
Smoking and the risk of fracture in older men. J Bone Miner Res (2005) 0.82
Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporos Int (2011) 0.81
Genetics of male osteoporosis. Calcif Tissue Int (2001) 0.80
The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. J Osteoporos (2011) 0.80
Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J Bone Miner Res (1998) 0.76
Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone (2012) 0.76
Idiopathic osteoporosis in men. Curr Osteoporos Rep (2013) 0.75